DNAJB1 and neoplasm: For the first time, our present study has identified HSP70‐1A and dnaJ‐B1 as direct target molecules of GO‐Y030 and demonstrated that the inhibition of HSP70/HSP40 function is the primary action of GO‐Y030 for its tumor‐suppressive effects.